Ambulatory blood pressure monitoring for detecting the relation between angiotensinogen gene polymorphism and hypertension

American Journal of Hypertension

Volumn 10, Issue 6, 1997, Pages 687-691

  Gharavi, Ali G ^a   Lipkowitz, Michael L ^a   Diamond, Joseph A ^a   Chamie, Rima ^a   Phillips, Robert A ^a  

^a Cardiovasc Inst Div Nephrology M   (United States)

Author keywords

Ambulatory blood pressure monitoring; Angiotensinogen gene; Hypertension

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL;

ADULT; ANGIOTENSINOGEN; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0030795837     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00097-6     Document Type: Article

References (20)

1. Pickering TP, James G, Boddie C, et al. How common is white coat hypertension? JAMA. 259:1988;225-228.
2. Verdecchia P, Schillaci G, Borgioni C, et al. White coat hypertension and white coat effect: similarities and differences. Am J Hyperten. 8:1995;790-798.
3. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis. Hypertension. 24:1994;793-801.
4. Devereux RB, Pickering TG, Harshfield GA. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regular recurring stress. Circulation. 68:1983;470-476.
5. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA. 249:1983;2792-2798.
6. Weber M, Cheung D, Graettinger W, et al. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. JAMA. 259:1988;3281-3285.
7. Conway J, Coats A, Radaeli A. Ambulatory blood pressure in relation to drug treatment and clinical trials. J Hypertens. 8:((suppl 6)):1990;S83-S85.
8. Schwartz GL, Turner ST, Sing CF. Association of genetic variation with interindividual variation in ambulatory blood pressure. J Hypertens. 14:1996;251-258.
9. Degaute JP, Cauter EV, van de Borne P, et al. Twenty four blood and heart rate profiles in humans: a twin study. Hypertension. 23:1994;244-253.
10. Jeunemaitre X, Soubrier F, Kotelevtsev Y, et al. Molecular basis of hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
11. Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 93:1994;2185-2187.
12. Iwai N, Shimoike H, Ohmichi N, et al. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension. 25:((part 2)):1995;688-693.
13. Katsuya T, Koike G, Yee T, et al. Association of the angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.
14. Caufield M, Lavende P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330:1994;1629-1633.
15. Caufield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus with human essential hypertension in African Caribbeans. J Clin Invest. 96:1995;687-692.
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 55:1977;613-618.
17. Rutledge D, Browe C, Kubilis P. Analysis of two variants of the angiotensinogen in essential hypertensive African-Americans. Am J Hypertens. 7:1994;651-654.
18. Reeves R. Does this patient have hypertension? JAMA. 273:1995;1211-1218.
19. 235→Thr variant of the angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 197:1993;833-839.
20. Fornage M, Turner S, Sing C, et al. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Gen. 96:1995;295-300.